Deloitte will look into a range of issues that also underpinned the 2019 review led by Professor Lloyd Sansom AO, including the "effectiveness, efficiency and appropriateness of the work delivered by NPS MedicineWise" and its governance and administrative arrangements.
New review of NPS Medicinewise a virtual 're-run' of previous process
July 13, 2022 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
TGA approves GSK's six‑monthly treatment for severe eosinophilic asthma and nasal polyps
July 28, 2026 - - Latest News -
Long-COVID still reshaping life for medically vulnerable Australians
July 28, 2026 - - Latest News -
Australians with rare diseases still waiting too long for access to treatments
July 28, 2026 - - Latest News -
New research shows chronic pain is widespread and undertreated in Australia
July 28, 2026 - - Latest News -
Bellberry announces new appointment to board of directors
July 27, 2026 - - Latest News -
The power of this commitment might be as a comparison of national intent
July 27, 2026 - - Latest News -
New AI platform aims to give patients a strong voice in medicines funding
July 27, 2026 - - Latest News

